SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

MGNX - MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.